Arcadia Biosciences, Inc.
through Jun 26, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Jan 27, 2026 · D | Jun 26, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $6,024,289 | $11,417,964 | $5,393,675 |
| Reported amount sold | $2,082,132 | $3,999,613 | $1,917,481 |
| Reported investor count | — | 5 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001469443-26-000001 · Later SEC source: 0001469443-26-000002
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $11,417,964
- Reported amount sold
- $3,999,613
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (2)
-
0001469443-26-000002D · Jun 26, 2026 · Other TechnologyOffering: $11,417,964Sold: $3,999,613
-
0001469443-26-000001D · Jan 27, 2026 · Other TechnologyOffering: $6,024,289Sold: $2,082,132